252 related articles for article (PubMed ID: 32896976)
1. Combining Inorganic Chemistry and Biology: The Underestimated Potential of Metal Complexes in Medicine.
Karges J
Chembiochem; 2020 Nov; 21(21):3044-3046. PubMed ID: 32896976
[TBL] [Abstract][Full Text] [Related]
2. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
Mahapatra DK; Bharti SK; Asati V; Singh SK
Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
[TBL] [Abstract][Full Text] [Related]
3. Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?
McFarland SA; Mandel A; Dumoulin-White R; Gasser G
Curr Opin Chem Biol; 2020 Jun; 56():23-27. PubMed ID: 31759225
[TBL] [Abstract][Full Text] [Related]
4. Increased Lipophilicity of Halogenated Ruthenium(II) Polypyridyl Complexes Leads to Decreased Phototoxicity in vitro when Used as Photosensitizers for Photodynamic Therapy.
Roy S; Colombo E; Vinck R; Mari C; Rubbiani R; Patra M; Gasser G
Chembiochem; 2020 Oct; 21(20):2966-2973. PubMed ID: 32473056
[TBL] [Abstract][Full Text] [Related]
5. Future potential of osmium complexes as anticancer drug candidates, photosensitizers and organelle-targeted probes.
Zhang P; Huang H
Dalton Trans; 2018 Oct; 47(42):14841-14854. PubMed ID: 30325378
[TBL] [Abstract][Full Text] [Related]
6. A Multi-action and Multi-target Ru
Karges J; Yempala T; Tharaud M; Gibson D; Gasser G
Angew Chem Int Ed Engl; 2020 Apr; 59(18):7069-7075. PubMed ID: 32017379
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of Ru(ii) polypyridyl complexes in living cells upon light irradiation.
Jakubaszek M; Goud B; Ferrari S; Gasser G
Chem Commun (Camb); 2018 Nov; 54(93):13040-13059. PubMed ID: 30398487
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium(II) complexes as bioorthogonal two-photon photosensitizers for tumour-specific photodynamic therapy against triple-negative breast cancer cells.
Lin M; Zou S; Liao X; Chen Y; Luo D; Ji L; Chao H
Chem Commun (Camb); 2021 May; 57(36):4408-4411. PubMed ID: 33949487
[TBL] [Abstract][Full Text] [Related]
9. Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy.
Karges J; Díaz-García D; Prashar S; Gómez-Ruiz S; Gasser G
ACS Appl Bio Mater; 2021 May; 4(5):4394-4405. PubMed ID: 35006851
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the mechanisms of action and subcellular localization of ruthenium(II)-based photosensitizers.
Mo J; Mai Le NP; Priefer R
Eur J Med Chem; 2021 Dec; 225():113770. PubMed ID: 34403979
[TBL] [Abstract][Full Text] [Related]
11. Cancer-Cell-Activated in situ Synthesis of Mitochondria-Targeting AIE Photosensitizer for Precise Photodynamic Therapy.
Wang Y; Xu S; Shi L; Teh C; Qi G; Liu B
Angew Chem Int Ed Engl; 2021 Jun; 60(27):14945-14953. PubMed ID: 33887096
[TBL] [Abstract][Full Text] [Related]
12. Unmasking Arene Ruthenium Building Blocks.
Therrien B
Chem Rec; 2021 Mar; 21(3):460-468. PubMed ID: 33215871
[TBL] [Abstract][Full Text] [Related]
13. Polymeric Encapsulation of Novel Homoleptic Bis(dipyrrinato) Zinc(II) Complexes with Long Lifetimes for Applications as Photodynamic Therapy Photosensitisers.
Karges J; Basu U; Blacque O; Chao H; Gasser G
Angew Chem Int Ed Engl; 2019 Oct; 58(40):14334-14340. PubMed ID: 31386250
[TBL] [Abstract][Full Text] [Related]
14. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
Qin WW; Pan ZY; Cai DH; Li Y; He L
Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
[TBL] [Abstract][Full Text] [Related]
15. BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT.
Bhattacharyya A; Jameei A; Karande AA; Chakravarty AR
Eur J Med Chem; 2021 Aug; 220():113438. PubMed ID: 33915370
[TBL] [Abstract][Full Text] [Related]
16. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B
Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560
[TBL] [Abstract][Full Text] [Related]
17. Self-Assembly of Porphyrin-Containing Metalla-Assemblies and Cancer Photodynamic Therapy.
Jiang X; Zhou Z; Yang H; Shan C; Yu H; Wojtas L; Zhang M; Mao Z; Wang M; Stang PJ
Inorg Chem; 2020 Jun; 59(11):7380-7388. PubMed ID: 31961145
[TBL] [Abstract][Full Text] [Related]
18. Strained ruthenium complexes are potent light-activated anticancer agents.
Howerton BS; Heidary DK; Glazer EC
J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
[TBL] [Abstract][Full Text] [Related]
19. A biotinylated ruthenium(ii) photosensitizer for tumor-targeted two-photon photodynamic therapy.
Li J; Zeng L; Xiong K; Rees TW; Jin C; Wu W; Chen Y; Ji L; Chao H
Chem Commun (Camb); 2019 Sep; 55(73):10972-10975. PubMed ID: 31453611
[TBL] [Abstract][Full Text] [Related]
20. LMCT transition-based red-light photochemotherapy using a tumour-selective ferrocenyl iron(iii) coumarin conjugate.
Sarkar T; Bhattacharyya A; Banerjee S; Hussain A
Chem Commun (Camb); 2020 Jul; 56(57):7981-7984. PubMed ID: 32538387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
